UA93875C2 - Isolated chimeric or humanized antibody that binds to a tat10772 (ca125) polypeptide - Google Patents

Isolated chimeric or humanized antibody that binds to a tat10772 (ca125) polypeptide

Info

Publication number
UA93875C2
UA93875C2 UAA200800374A UAA200800374A UA93875C2 UA 93875 C2 UA93875 C2 UA 93875C2 UA A200800374 A UAA200800374 A UA A200800374A UA A200800374 A UAA200800374 A UA A200800374A UA 93875 C2 UA93875 C2 UA 93875C2
Authority
UA
Ukraine
Prior art keywords
tat10772
polypeptide
binds
humanized antibody
isolated chimeric
Prior art date
Application number
UAA200800374A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марк ДЕННИС
Вилльям Маллет
Пол Полакис
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of UA93875C2 publication Critical patent/UA93875C2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to an isolated chimeric or humanized antibody 3А5 that binds to a TAT10772 (CA125) polypeptide with high affinity. The invention further relates to an antibody-drug conjugate, to a pharmaceutical composition comprising the antibody, a method of inhibiting the growth of a cell, a method of treating a cancerous tumor, a method of determining the presence of a cancer cell using the antibody etc.
UAA200800374A 2005-06-20 2006-06-14 Isolated chimeric or humanized antibody that binds to a tat10772 (ca125) polypeptide UA93875C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69209205P 2005-06-20 2005-06-20

Publications (1)

Publication Number Publication Date
UA93875C2 true UA93875C2 (en) 2011-03-25

Family

ID=41290406

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800374A UA93875C2 (en) 2005-06-20 2006-06-14 Isolated chimeric or humanized antibody that binds to a tat10772 (ca125) polypeptide

Country Status (3)

Country Link
CN (1) CN101595130B (en)
UA (1) UA93875C2 (en)
ZA (1) ZA200710321B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763164A (en) * 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
EP1551876B1 (en) * 2002-10-16 2011-03-16 Purdue Pharma L.P. Antibodies that bind cell-associated ca 125/0722p and methods of use thereof

Also Published As

Publication number Publication date
CN101595130B (en) 2012-05-16
CN101595130A (en) 2009-12-02
ZA200710321B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
IL258880A (en) Diarylhydantoin compounds
PL1896507T3 (en) Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells
UA114879C2 (en) CD38 ANTIBODY FOR CANCER TREATMENT
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
MX2009012732A (en) Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity.
PL2097453T3 (en) Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii)
TW200617022A (en) Anti-glypican 3 antibody
TNSN08548A1 (en) Prlr-specific antibody and uses thereof
WO2006099141A3 (en) Anti-mesothelin antibodies
MX2020011789A (en) Monoclonal antibodies against claudin-18 for treatment of cancer.
TW200639182A (en) Antibody variants and uses thereof
WO2008116219A3 (en) Uses of monoclonal antibody 8h9
WO2005080431A3 (en) Monoclonal antibodies that specifically bind to folate receptor alpha
UA94707C2 (en) Antigen-binding molecule capable of binding to plgf
UA106194C2 (en) Diagnosis and treatment of cancer using anti-ereg antibody
UA99602C2 (en) Antibody that specifically binds to jam-a, capable of inhibiting the proliferation of tumor cells
WO2005090406A3 (en) Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
TNSN08401A1 (en) Methods of treating diagnosing or detecting cancer
WO2007059190A3 (en) Compositions of and methods of using stabilized psma dimers
MX2009001014A (en) Cytotoxicity mediation of cells evidencing surface expression of cd63.
UA93875C2 (en) Isolated chimeric or humanized antibody that binds to a tat10772 (ca125) polypeptide
HK1116198A1 (en) Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
UA100694C2 (en) Antibody that specifically binds to cd79b, immunoconjugate and uses thereof
PE20091437A1 (en) CANCER DISEASE MODIFYING ANTIBODIES